Literature DB >> 25289958

Interleukin 2: the molecule and its function.

R J Robb1.   

Abstract

IL2 plays an essential role in triggering proliferation of activated T cells, a response mediated by interaction of the factor with a high-affinity membrane receptor. IL2 also influences a number of other cellular responses, including natural killer cell activity and antibody secretion. Thus, directly or indirectly, IL2 has the properties of both a growth factor and a differentiation signal. Both IL2 and its receptor have been purified to homogeneity and extensively characterized at the molecular level. In this review, Richard Robb discusses the current biochemical understanding of IL2 and its receptor and new information relating to its role in cellular responses.
Copyright © 1984. Published by Elsevier B.V.

Entities:  

Year:  1984        PMID: 25289958     DOI: 10.1016/0167-5699(84)90224-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  31 in total

Review 1.  Regulatory T cell-based therapies for autoimmunity.

Authors:  Benjamine Arellano; David J Graber; Charles L Sentman
Journal:  Discov Med       Date:  2016-08       Impact factor: 2.970

2.  Immunoregulatory lymphokines in rheumatoid joints. II. Production by and responsiveness to interleukin-2 of eluted synovial tissue cells.

Authors:  J Hovdenes; T Egeland
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

3.  In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis.

Authors:  H E Prince; S H Kleinman; V C Maino; A L Jackson
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

Review 4.  Soluble inhibitors of T lymphocyte proliferation: tools for dissecting pathways of T cell activation.

Authors:  J C Reed; P C Nowell
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  The importance of protease histochemistry in pathology.

Authors:  Z Lojda
Journal:  Histochem J       Date:  1985-10

Review 6.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

7.  Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.

Authors:  P J Guillou; G R Giles; C W Ramsden
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

8.  Impaired T-cell activation in patients with systemic lupus erythematosus.

Authors:  S Sierakowski; E J Kucharz; R W Lightfoot; J S Goodwin
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

9.  Effect of tumor-derived immunosuppressive factor(s) on interleukin 2 and on expression of interleukin 2 receptor.

Authors:  R D Wang; Y Luo; Z H Feng; Z C Chen
Journal:  J Tongji Med Univ       Date:  1990

10.  The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.

Authors:  C Y Lin; C C Lin; B Hwang; B N Chiang
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.